Together, our study suggests that HDAC7 in astrocytes regulates tau clearance via the control of TFEB lysosomal pathway, and inhibition of astrocytic HDAC7 is a potential therapeutic strategy for AD and other tau-mediated neurodegeneration. Here, HDAC7 is linked to Alzheimer disease.